🇺🇸 FDA
Patent

US 11007248

Suppression of allergic lung inflammation and hyperreactivity

granted A61KA61K38/10A61K38/1709

Quick answer

US patent 11007248 (Suppression of allergic lung inflammation and hyperreactivity) held by The Regents of the University of California expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/10, A61K38/1709, A61K38/177, A61K9/007